Dr Erica Bello | Postdoctoral Fellow

Bello, Erica

Publications

  • L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients.

    Bello E, Kerry J, Singh S, Yip BH, Kušec R et al.

    Haematologica 2018;103;11;e496-e500

  • CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).

    Bello E, Pellagatti A, Shaw J, Mecucci C, Kušec R et al.

    British journal of haematology 2015;171;2;210-214

  • ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.

    Valletta S, Dolatshad H, Bartenstein M, Yip BH, Bello E et al.

    Oncotarget 2015;6;42;44061-71

  • L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients.

    Bello E, Kerry J, Singh S, Yip BH, Kušec R et al.

    Haematologica 2018;103;11;e496-e500

  • ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.

    Valletta S, Dolatshad H, Bartenstein M, Yip BH, Bello E et al.

    Oncotarget 2015;6;42;44061-71

  • CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).

    Bello E, Pellagatti A, Shaw J, Mecucci C, Kušec R et al.

    British journal of haematology 2015;171;2;210-214

Bello, Erica
Erica's Timeline
2017

Joined the Sanger Insitute as a Postdoctoral Fellow

DPhil Medical Sciences, University of Oxford

2013

MSci Biomedical Sciences (Integrated Master), University of Newcastle-upon-Tyne